| 426 |
SARS-CoV-2 spike protein binding to ACE2 receptors expressed on pericytes leads to endothelial cell dysfunction, microvascular injury and myocardial infarction. |
Evangelos-Panagiotis Daskalopoulos |
BY-SA |
1739: Binding to ACE2
|
1934: Myocardial Infarction
|
|
|
| 425 |
Oxidative Stress Leading to Decreased Lung Function via Decreased FOXJ1 |
Karsta Luettich |
BY-SA |
1392: Increase, Oxidative Stress
|
1250: Decrease, Lung function
|
|
|
| 424 |
Oxidative stress Leading to Decreased Lung Function via CFTR dysfunction |
Karsta Luettich |
BY-SA |
1392: Increase, Oxidative Stress
|
1250: Decrease, Lung function
|
|
|
| 423 |
Toxicological mechanisms of hepatocyte apoptosis through the PARP1 dependent cell death pathway |
Fei Li |
BY-SA |
2 MIEs
|
1817: Apoptotic cell death
|
|
|
| 421 |
PPARG activation leading to intrahepatic cholestasis |
Yuan Jin |
BY-SA |
None
|
None
|
|
|
| 420 |
Aryl hydrocarbon receptor activation leading to lung cancer through sustained NRF2 toxicity pathway |
Dianke Yu |
BY-SA |
18: Activation, AhR
|
None
|
|
|
| 450 |
Inhibition of AChE and activation of CYP2E1 leading to sensory axonal peripheral neuropathy and mortality |
SAROJ AMAR |
BY-SA |
12: Acetylcholinesterase (AchE) Inhibition
|
2 AOs
|
|
|
| 451 |
Interaction with lung resident cell membrane components leads to lung cancer |
Penny Nymark |
BY-SA |
1495: Substance interaction with the lung resident cell membrane components
|
1670: Lung cancer
|
|
|
| 452 |
Adverse outcome pathway of PM-induced respiratory toxicity |
li qing |
BY-SA |
2007: Non-coding RNA expression profile alteration
|
2008: Chronic obstructive pulmonary disease
|
|
|
| 453 |
Reactive oxygen species and subsequent oxidative stress lead to increased incidence of digestive morbidity and mortality in the general population |
Ruiyang Ding |
BY-SA |
None
|
None
|
|
|
| 454 |
PM2.5-related AOP frameworks on liver diseases |
Zhou Du |
BY-SA |
None
|
None
|
|
|
| 457 |
Succinate dehydrogenase inhibition leading to increased insulin resistance through reduction in circulating thyroxine |
Simon Thomas |
Open for adoption |
2118: Succinate dehydrogenase, inhibited
|
2119: Increase, Insulin resistance
|
|
|
| 458 |
AhR activation in the liver leading to Subsequent Adverse Neurodevelopmental Outcomes in Mammals |
Prakash Patel |
Open for adoption |
18: Activation, AhR
|
402: Cognitive function, decreased
|
|
|
| 481 |
AOPs of amorphous silica nanoparticles: ROS-mediated oxidative stress increased respiratory dysfunction and diseases. |
Hailin Xu |
BY-SA |
1115: Increase, Reactive oxygen species
|
2 AOs
|
|
|
| 624 |
Increased 11β-Hydroxysteroid dehydrogenase type 1 activity leading to MASLD progression via insulin resistance-associated mitochondrial dysfunction |
You Song |
BY-SA |
2410: Increase, 11β-Hydroxysteroid dehydrogenase type 1 activity
|
4 AOs
|
Under Development |
|
| 625 |
Increased 11β-Hydroxysteroid dehydrogenase type 1 activity leading to MASLD progression via insulin resistance-associated oxidative stress |
You Song |
BY-SA |
2410: Increase, 11β-Hydroxysteroid dehydrogenase type 1 activity
|
4 AOs
|
Under Development |
|
| 626 |
Increased 11β-Hydroxysteroid dehydrogenase type 1 activity leading to MASLD progression via insulin resistance-associated endoplasmic reticulum stress |
You Song |
BY-SA |
2410: Increase, 11β-Hydroxysteroid dehydrogenase type 1 activity
|
4 AOs
|
Under Development |
|
| 8 |
Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals |
Katie Paul Friedman |
Open for adoption |
239: Activation, Pregnane-X receptor, NR1I2
|
319: Loss, Cochlear function
|
Under Development |
1.9 |
| 11 |
Percellome Toxicogenomics Approach for AOP Building: Case study on Pentachlorophenol |
Jun Kanno |
BY-SA |
245: Activation, PXR/SXR
|
None
|
Under Development |
2.5 |
| 627 |
Increased 11β-Hydroxysteroid dehydrogenase type 1 activity leading to MASLD progression via lipogenesis-associated mitochondrial dysfunction |
You Song |
BY-SA |
2410: Increase, 11β-Hydroxysteroid dehydrogenase type 1 activity
|
4 AOs
|
Under Development |
|
| 628 |
Increased 11β-Hydroxysteroid dehydrogenase type 1 activity leading to MASLD progression via lipogenesis-associated oxidative stress |
You Song |
BY-SA |
2410: Increase, 11β-Hydroxysteroid dehydrogenase type 1 activity
|
4 AOs
|
Under Development |
|
| 629 |
Increased 11β-Hydroxysteroid dehydrogenase type 1 activity leading to MASLD progression via lipogenesis-associated endoplasmic reticulum stress |
You Song |
BY-SA |
2410: Increase, 11β-Hydroxysteroid dehydrogenase type 1 activity
|
4 AOs
|
Under Development |
|
| 630 |
Decreased 11β-Hydroxysteroid dehydrogenase type 2 activity leading to MASLD progression via insulin resistance-associated mitochondrial dysfunction |
You Song |
BY-SA |
2409: Decrease, 11β-Hydroxysteroid dehydrogenase type 2 activity
|
None
|
Under Development |
|
| 475 |
Binding of chemicals to ionotropic glutamate receptors leads to impairment of learning and memory via loss of drebrin from dendritic spines of neurons |
Shihori Tanabe |
All rights reserved |
875: Binding of agonist, Ionotropic glutamate receptors
|
341: Impairment, Learning and memory
|
Under Development |
1.107 |
| 502 |
Decrease, cholesterol synthesis leads to orofacial clefting |
Jacob Reynolds |
BY-SA |
None
|
2042: Increase, Orofacial clefting
|
Under Development |
1.101 |